mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |